Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Pliant Therapeutics (PLRX) Receivables - Other (2020 - 2025)

Pliant Therapeutics (PLRX) has disclosed Receivables - Other for 6 consecutive years, with $823000.0 as the latest value for Q4 2025.

  • Quarterly Receivables - Other fell 64.25% to $823000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $823000.0 through Dec 2025, down 64.25% year-over-year, with the annual reading at $823000.0 for FY2025, 64.25% down from the prior year.
  • Receivables - Other for Q4 2025 was $823000.0 at Pliant Therapeutics, down from $908000.0 in the prior quarter.
  • The five-year high for Receivables - Other was $4.0 million in Q2 2022, with the low at $385000.0 in Q4 2021.
  • Average Receivables - Other over 5 years is $2.0 million, with a median of $2.1 million recorded in 2023.
  • The sharpest move saw Receivables - Other tumbled 95.86% in 2021, then surged 210.84% in 2023.
  • Over 5 years, Receivables - Other stood at $385000.0 in 2021, then surged by 938.96% to $4.0 million in 2022, then fell by 25.07% to $3.0 million in 2023, then dropped by 23.19% to $2.3 million in 2024, then crashed by 64.25% to $823000.0 in 2025.
  • According to Business Quant data, Receivables - Other over the past three periods came in at $823000.0, $908000.0, and $1.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.